Stay updated on VX15/Avelumab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VX15/Avelumab Combo in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version bump without altering the displayed study details.
    Difference
    0.1%
    Check dated 2026-04-27T08:10:37.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-20T05:16:44.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added a citation to iRECIST guidelines (Lancet Oncology 2017) in Publications and removed the Lancet Oncology 2019 erratum note from the same reference.
    Difference
    0.1%
    Check dated 2026-04-05T19:30:31.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-22T08:49:17.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Updated the iRECIST citation to revision v3.4.3, replacing the previous v3.4.2 citation.
    Difference
    0.1%
    Check dated 2026-03-07T19:16:21.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    A minor version update was applied: from v3.4.1 to v3.4.2, with no substantive content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T06:00:08.000Z thumbnail image

Stay in the know with updates to VX15/Avelumab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.